FDA Inspection 811049 — Reproductive Medicine Institute

Reproductive Medicine Institute — FEI 3009383018

The FDA completed an inspection of Reproductive Medicine Institute on December 20, 2012 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 20, 2012
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Chicago, IL (United States)